Application of non-invasive central aortic pressure assessment in clinical trials: Clinical experience and value

Pressure measured with a cuff and sphygmomanometer in the brachial artery is accepted as an important predictor of future cardiovascular (CV) events. However, recent clinical evidence suggests that central aortic pressure (CAP) provides additional information for assessing CV risk than brachial blood pressure (BrBP). Central hemodynamics can now be non-invasively assessed with a number of devices, however, the methodology employed to measure CAP, in order to better identify the patients at higher CV risk in clinical practice, is still controversial.

Source: Artery Research - November 24, 2016 Category: Cardiology Authors: Bryan Williams, Patrick Brunel, Peter S. Lacy, Fabio Baschiera, Dion H. Zappe, Kazuomi Kario, John Cockcroft Tags: Review Source Type: research